NIW Petition Approved for Attending Physician from Ecuador in the Field of Clinical Research

 

Client’s Testimonial:

“I am happy to inform you that I have received the I-797 approval notice for my National Interest Waiver case.”


On February 11th, 2016, we received another EB-2 NIW (National Interest Waiver) approval for an Attending Physician in the Field of Clinical Research (Approval Notice).


General Field: Clinical Research

Position at the Time of Case Filing: Attending Physician

Country of Origin: Ecuador

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Florida

Approval Notice Date: February 11th, 2016

Processing Time: 5 months, 9 days

 


Case Summary:

 

“She has already made large advancements in some of the most common health concerns occurring in the United States today; high cholesterol, heart disease, liver dysfunction and drug interaction. [Client] is a unique researcher with a background especially suited to research in such pressing fields. Her skills and thorough methodologies place above her colleagues; I look forward to seeing her work continue.”

This strong statement is excerpted from a recommendation letter offered by a prominent professor working at one of the country’s top medical colleges. His letter, along with several others that our Ecuadorian client gathered from other experts in her field of clinical research, were incorporated into the EB-2 NIW (National Interest Waiver) petition packet that she hired North America Immigration Law Group to put together.

Our legal team compiled a list of our client’s accomplishments to prove to the USCIS that her work is of the utmost importance to the United States, particularly to the country’s medical sector. Her findings related to dyslipidemia and Type 1 Diabetes serve as evidence that not many other researchers with similar qualifications can mirror her achievements. Furthermore, we detailed her 5 publications that had gathered 83 citations when we filed her case.

The USCIS spent a little over five months adjudicating our client’s EB-2 NIW petition. We are currently helping this attending physician prepare her I-485 application (final step in the green card process) and we wish her all the best in obtaining her permanent residency.


 

 

We are pleased to announce that North America Immigration Law Group has so far received over 3,500 EB-1A, EB-1B and EB-2 NIW approval notices. In 2014 and 2015, the approval rate is 98.22% for cases using our "Approval or Refund®" (money back guarantee) service and 96.95% for all kinds of services.

For NIW cases, the approval rate is 99.18% for cases using our "Approval or Refund®" (money back guarantee) service and the overall approval rate for all NIW cases is 98.47%.

For EB1A cases, the approval rate is 97.25% for "Approval or Refund®" (money back guarantee) service and the overall approval rate for all EB1A cases is 95.27%.

We are one of the leading U.S. immigration law firms providing the most comprehensive services for EB-1/NIW petition with a large volume of approval cases and high approval rate.

Our staff keeps close track of the latest immigration trends and regulations of USCIS (U.S. Citizenship and Immigration Services), decisions of AAO (Administrative Appeal Office) and judicial review opinions. The massive collected materials contribute to the most convincing arguments and winning strategies of our firm for EB1A, EB1B, and NIW petitions.

If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.


Approval Notices: http://www.wegreened.com/eb1_niw_approvals

Success Stories: http://blog.wegreened.com/

Website: www.wegreened.com

Free evaluation email: law@wegreened.com

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.